BioCryst Pharmaceuticals
BCRX
BCRX
238 hedge funds and large institutions have $915M invested in BioCryst Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 84 increasing their positions, 71 reducing their positions, and 27 closing their positions.
Holders
238
Holders Change
+3
Holders Change %
+1.28%
% of All Funds
3.45%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
31
Increased
84
Reduced
71
Closed
27
Calls
$7.81M
Puts
$9.31M
Net Calls
-$1.5M
Net Calls Change
-$14.5M
Top Buyers
Top Sellers
1 |
1
Morgan Stanley
New York
|
$10.2M |
2 |
B
2
Braidwell
Stamford,
Connecticut
|
$17.2M |
3 |
3
Balyasny Asset Management
Chicago,
Illinois
|
$0 |
4 |
4
Norges Bank
Oslo,
Norway
|
$5.11M |
5 |
![]()
5
Fidelity Investments
Boston,
Massachusetts
|
$9.32M |